Barry Berger is Professor of Regulatory Affairs, at Temple University’s, School of Pharmacy, QA/RA Graduate Program. Prior, to his appointment to the full time faculty, Mr. Berger had served in senior positions with both multinational and startup pharmaceutical and biotech companies.
Mr. Kitchens is a partner at Arnall Golden Gregory LLP where he served as the Managing Partner from 1996-2008. His practice focuses on food and drug law and government investigations He is an adjunct professor at Emory University School of Law where he has taught food and drug law since 1979.
William Vodra, JD, recently retired from the active practice of law at Arnold & Porter after over 30 years, where he specialized in crisis management and regulatory issues involving the safety, effectiveness, quality, and marketing of medical products.
Description
This forum will explore policy and enforcement trends and explore issues addressing questions related to the issue of whether regulators/industry are heading in the right direction. As globalization and collaboration become more relevant, can we do better?
Learning Objectives: Describe major regulatory enforcement trends and how industry should react Discuss some ways industry can deal better with globalization Discuss economic challenges and explore collaborations among regulators and between regulators and industry.